middle.news

Memphasys Raises $0.84m, Slashes Costs 40% to Boost Felix™ Rollout

9:25am on Monday 22nd of September, 2025 AEST Healthcare
Read Story

Memphasys Raises $0.84m, Slashes Costs 40% to Boost Felix™ Rollout

9:25am on Monday 22nd of September, 2025 AEST
Key Points
  • Placement raises $0.84 million with strong institutional and existing investor support
  • Non-renounceable rights issue planned to raise up to $1.12 million
  • Operating costs cut by 40%, from $3 million to $1.8 million in CY2026
  • Funds directed to contract delivery, manufacturing scale-up, and regulatory progress
Read Story
middle.

Tap to Read

Tap the card to read the full analysis
about Memphasys (ASX:MEM)
OPEN ARTICLE